These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9656971)

  • 21. Imaging the neurochemistry of alcohol and substance abuse.
    Martinez D; Kim JH; Krystal J; Abi-Dargham A
    Neuroimaging Clin N Am; 2007 Nov; 17(4):539-55, x. PubMed ID: 17983969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analytical toxicology of emerging drugs of abuse--an update.
    Meyer MR; Peters FT
    Ther Drug Monit; 2012 Dec; 34(6):615-21. PubMed ID: 23131695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain imaging in nonhuman primates: insights into drug addiction.
    Nader MA; Czoty PW
    ILAR J; 2008; 49(1):89-102. PubMed ID: 18172336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addiction: brain mechanisms and their treatment implications.
    Nutt DJ
    Lancet; 1996 Jan; 347(8993):31-6. PubMed ID: 8531549
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation.
    Gould RW; Porrino LJ; Nader MA
    Curr Top Behav Neurosci; 2012; 11():25-44. PubMed ID: 22020537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroimaging and mechanisms of drug abuse: interface of molecular imaging and molecular genetics.
    Ernst M; Kimes AS; Jazbec S
    Neuroimaging Clin N Am; 2003 Nov; 13(4):833-49. PubMed ID: 15024965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging receptor changes in human drug abusers.
    Cosgrove KP
    Curr Top Behav Neurosci; 2010; 3():199-217. PubMed ID: 21161754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of 'ecstasy' abuse on the human brain studied by FDG PET.
    Buchert R; Obrocki J; Thomasius R; Väterlein O; Petersen K; Jenicke L; Bohuslavizki KH; Clausen M
    Nucl Med Commun; 2001 Aug; 22(8):889-97. PubMed ID: 11473208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of positron emission tomography to study cocaine in the human brain.
    Volkow ND; Fowler JS; Wolf AP
    NIDA Res Monogr; 1991; 112():168-79. PubMed ID: 1753998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging opiate receptors in the human brain with positron emission tomography. Potential applications for drug addiction research.
    Sadzot B; Mayberg HS; Frost JJ
    Acta Psychiatr Belg; 1990; 90(1):9-19. PubMed ID: 1670391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural imaging for addiction medicine: From neurostructure to neuroplasticity.
    Brown GG; Jacobus J; McKenna B
    Prog Brain Res; 2016; 224():105-27. PubMed ID: 26822356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neural correlates of hot and cold executive functions in polysubstance addiction: association between neuropsychological performance and resting brain metabolism as measured by positron emission tomography.
    Moreno-López L; Stamatakis EA; Fernández-Serrano MJ; Gómez-Río M; Rodríguez-Fernández A; Pérez-García M; Verdejo-García A
    Psychiatry Res; 2012; 203(2-3):214-21. PubMed ID: 22959812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cocaine addiction: hypothesis derived from imaging studies with PET.
    Volkow ND; Ding YS; Fowler JS; Wang GJ
    J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The addicted brain: imaging neurological complications of recreational drug abuse.
    Montoya-Filardi A; Mazón M
    Radiologia; 2017; 59(1):17-30. PubMed ID: 27773463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO.
    Boileau I; Nakajima S; Payer D
    Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiological and neurological changes in the drug abuse patient: a study with MRI.
    Volkow ND; Valentine A; Kulkarni M
    J Neuroradiol; 1988; 15(3):288-93. PubMed ID: 3266757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of neurotoxicity from potential medications for drug abuse: ibogaine testing and brain imaging.
    Vocci FJ; London ED
    Ann N Y Acad Sci; 1997 May; 820():29-39; discussion 39-40. PubMed ID: 9237447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualizing the firestorms in the brain: an inside look at the clinical and physiological connections between drugs and violence using brain SPECT imaging.
    Amen DG; Yantis S; Trudeau J; Stubblefield MS; Halverstadt JS
    J Psychoactive Drugs; 1997; 29(4):307-19. PubMed ID: 9460024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights from recent positron emission tomographic studies of drug abuse and dependence.
    Chang L; Haning W
    Curr Opin Psychiatry; 2006 May; 19(3):246-52. PubMed ID: 16612209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging the roles of the amygdala in drug addiction.
    Kilts CD
    Psychopharmacol Bull; 2001; 35(1):84-94. PubMed ID: 12397873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.